Luxna Biotech is a Japanese preclinical antisense oligonucleotide drug development company based in Osaka, founded on proprietary modified nucleic acid technology from Osaka University. Their core business is developing nucleic acid medicines using proprietary bridged nucleic acid structures (AmNA, scpBNA, GuNA). They offer XNAs technology licensing and monomer supply, and have a collaboration with BioSpring for custom oligonucleotide manufacturing. They are a drug discovery company, not a contract manufacturer.
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.